CoChat

Sixteenth Gaddum Memorial Lecture December 1996. Neuroimmune interactions: the role of cytokines

Open access
Rothwell, Nancy J · 1997 · British Journal of Pharmacology
Cited by 71

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The concept of the brain as an 'immune privileged' organ has been modified significantly with the realization that interactions between the nervous and immune systems are important in many aspects of disease and injury. Peripheral infection, inflammation and injury activate afferent neuronal and homoral signals to the brain, which in turn influence or regulate specific aspects of the host acute phase response. Many molecules and pathways associated with immune or inflammatory responses have been identified within the central nervous system and are activated in response to peripheral disease or injury and diverse neurological disorders. Cytokines are polypeptide mediators most widely associated with the inflammation and immunity in the periphery and play a key role in many of these interactions. This review will focus mainly on the 'proinflammatory cytokines', interleukin-1 (IL-1), IL-6 and tumour necrosis factor α (TNFα), which are expressed by, and act on the brain, and have been implicated in many aspects of neu-roimmunology. The host defence response, also known as the acute phase response, includes changes on both local (eg inflammation within specific tissues) and systemic functions. The central nervous system regulates important aspects of this response including fever, anorexia, hypermetabolism, neuroendocrine changes (most notably activation of the hypothalamic-pituitary-adrenal, axis), alterations in behaviour, cardiovascular and reproductive function and even some aspects of immune activation. Much of our understanding of the local and afferent pathways regulating these changes has derived from studies on fever. Fever is still one of the most widely used diagnostic tools in clinical medicine, it is a phylogen-etically old response which has even been observed in poi-kilotherms, can be readily and continuously monitored in free-moving subjects and animals by remote radiotelemetry, and appears to share common mechanisms with several central nervous system-dependent acute phase responses (Kluger, 1991; Roberts, 1991). Studies on fever and other neuroimmune responses in rodents have most often used systemic (intraperitoneal or intravenous) administration of bacterial lipopolysaccharide as a stimulus, which has provided much valuable information on fever and other central nervous system responses to infection (eg see Kluger, 1991). However, this approach has several potential disadvantages. High doses of lipopolysaccharide are required to induce fever in rats and mice, so injected lipopolysaccharide could act at numerous sites including in the brain itself, and it is not possible to study local pathways or mediators within specific sites of infection or inflammation. Nevertheless, lipopolysaccharide-induced fever is associated with dramatic increases in circulating IL-6 and release of cytokines in the brain and is inhibited by blocking IL-1 actions at both sites (Le May et al., 1990; Rothwell et al., 1991). We have previously demonstrated that a sterile abscess induced by an intramuscular injection of turpentine (which does not diffuse into circulation) also elicits marked fever in the rat and, like lipopolysaccharide, is associated with increases in circulating IL-6 of many orders of magnitude (Turnbull et al., 1992; Cooper et al., 1994; Miller et al., 1997b). Indeed circulating IL-6 levels correlate with the rising phase of fever, although there may be a threshold level for IL-6, or existence of co-factors which are required to act synergistically with IL-6 in pyrogenesis (Turnbull, 1993). However, in these and many other experimental systems, little or no increase in circulating IL-1 is detected in circulation, although blocking IL-1 by injection of a neutralizing antibody or recombinant interleukin-1 receptor antagonist (IL-1ra) significantly attenuates fever (Long et al., 1990; Miller et al., 1997a). These data question the hypothesis that IL-1 is the primary circulating endogenous pyrogen, but nevertheless indicate an important role in fever and suggest that it may act locally within infected or inflamed tissue. In order to address these issues we have studied the effects of administering pyrogens into a sterile, subcutaneous air pouch which allows sampling of local cytokine production and modification of cytokine activities within the air pouch without direct effects of the stimulus on distant tissues. Injection of lipopolysaccharide (100 μg kg−1) into such an air pouch in the rat elicits marked fever, of comparable magnitude to that seen in response to intraperitoneal injection of lipopolysaccharide. No increases in bioactive IL-1 or TNFα are identified in circulation (Figure 1) in response to either stimulus, but the bioactivity of both of these cytokines increases dramatically (30–1000 fold) in fluid sampled from the air pouch after lipopolysaccharide (Miller, 1996; Miller et al., 1997a, b). TNFα is the first cytokine detected (by 30 min after lipopolysaccharide) in the air pouch, followed by

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0701248

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 71

Metadata

Authors
Rothwell, N. J.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1997-07
Volume
121
Issue
5
Pages
841-847
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2064404352
Cited by
71
References
5
FWCI
6.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.